Philip Morris
Edward V. Morse Ph.D. Clinical Professor of Psychiatry at Lsumcno
Fields
- Author
- Morse, E.V.
- Type
- TRAN, TRANSCRIPT
- Area
- ELLIS,CATHY/OFFICE
- Named Organization
- FDA, Food and Drug Administration
- Hhs, Dept of Health and Human Services
- Site
- R461
- Named Person
- Clinton
- Author (Organization)
- La State Univ Medical Center
- Lsumcno
- Master ID
- 2057063515/3727
Related Documents:- 2057063515-3522 Before the United States Food and Drug Administration Docket No. 95n-0253 Docket No. 95n-0253j Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products to Protect Children and Adolescents, Proposed Rule, Analysis Regarding FDA's Jurisdiction Over Nicotine - Containing Cigarettes and Smokeless Tobacco Products, Notice Comments of Brown & Williamson Tobacco Corporation Liggett Group Inc. Lorillard Tobacco Company Philip Morris Incorporated R.J. Reynolds Tobacco Company Tobacco Institute Inc. Volume Viii
- 2057063523-3542 Professor Timothy P. Meyer University of Wisconsin, Green Bay
- 2057063576-3583 Lucy Henke
- 2057063589-3595 Professor J. Stephen Thomas
- 2057063600-3621 Public Policy Decisions Should Be Based on Sound Social Science Research, Not Speculation or Political Motivation.
- 2057063633-3636 Dr. Linda D. Goff
- 2057063645-3651 Charles F. 'rick' Houlberg
- 2057063653-3660 Paul J. Traudt, Ph.D.
- 2057063669-3673 Comments to FDA
- 2057063684-3701 Comments by W. Kip Viscusi on FDA Notice of Findings, 'regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products to Protect Children and Adolescents: Findings of the Focus Group Testing of Brief Statements for Cigarette Advertisements,' 60 Fed. Reg. 61,670-79 (95101)
- 2057063708-3727 Bibliography of W. Kip Viscusi
- Litigation
- Iwoh/Produced
- Date Loaded
- 17 Apr 1999
- UCSF Legacy ID
- wgs13e00
Document Images
Edward V. Morse Ph.D.
Clinical Professor of Psychiatry at LSUMCNO.
I am Edward V. Morse, a clinical Professor of Psychiatry at the Louisiana State
University Medical Center in New Orleans, Louisiana. I hold a PhD from Cornell. My
area of specialization is Sociology with a concentration in behavioral medicine.
For the last twenty five years I have taught and conducted extensive research in
behavioral medicine -- the complex subject of the determinates of human behavior --
particularly risky behavior -- and how to develop effective public policies to alter peoples'
health behavior patterns. Within the field of behavioral medicine, I have concentrated
on health issues raised by the behavior patterns of children, and adolescents, and young
adults.
I have served as a consultant to the United States Department of Health and
Human Services, the State of Louisiana (public schools and school-based health care
programs) and other private and government agencies to help translate research findings
into effective public health policy. Most recently, I was invited by President Clinton to
meet with him and to advise him with regard to the formulation of HIV policy and
substance abuse -- to develop policies and programs to try to alter persons' risky health
behavior patterns in an effort to stop the spread of the HIV infection. I have presented
and published nationally as well as internationally in the area of determinates of HIV
prevention behavior. A copy of my CV is attached.
During the last decade I have had an extensive opportunity to deal with health
issues as they are related to the behavior patterns of children and adolescents. The most
common mistake made by "Policy-Makers" in attempting to alter people's behavior is the
false assumption that knowledge and attitudes work together to shape behavior practices.
In the health field this is referred to as the "KAP" model --Knowledge/Attitudes/Practices.
The false assumption of this model -- upon which many programs have been based -- is
the assumption that people's behavioral patterns can be controlled or altered by
controlling or altering their "knowledge" about the behavior.
Time and again, policy-makers and the public have been disappointed -- and
surprised -- that campaigns based on the KAP model have been unsuccessful in bringing
about the desired change in people's behavior. In general, the KAP model is very
attractive to policy-makers because it appears to offer an easy way to alter an individual's
or group's behavior patterns. The theory is, simply alter a group's access to a particular
type of information and the desired change in behavior will follow. As a practical matter,
the reality is that human behavior is not so simplistic -- the determinates of human
behavior patterns are complex, and are not simply changed by altering information
resources. The KAP model totally ignores or discounts important cultural information,
age differences, developmental differences, how these factors interact -- and change over
time.

!
0
The fact that human behavior patterns are extremely complex, and that public
policy attempts to alter behavior patterns through controlling information are bound to
be ineffective, has been demonstrated repeatedly in the behavioral research on HIV
transmission. The nation's policies regarding AIDS and the prevention of the spread of
HIV have depended heavily on the KAP model and to date have had no significant
impact. FDA's proposed tobacco regulations are also firmly and directly based on the
KAP model -- FDA is proposing to alter teenagers' smoking behavior by changing their
exposure to cigarette advertising and health warnings. FDA's proposal is likely to be no
more effective in altering the behavior patterns of adolescents than other, similarly
miscast policies.
In reviewing the proposed FDA regulations, I noted that the agency has adopted
the intuitive appeal of the idea that altering information available to an individual will be
followed by a change in attitudes and behavior patterns. In my opinion -- and based on
my experience and understanding of human behavior and the behavior patterns of
children and adolescents -- such a policy is not likely to have any meaningful impact on
underage smoking.
There are a number of specific reasons why FDA's proposed policy is not likely to
be effective in reducing underage smoking.
First, children and adolescents already have the "knowledge" and the "attitude"
that smoking is unhealthy.
Second, we know from decades of research and observation that childrens' and
adolescents' "patterns" of smoking behavior are most likely to be determined by the
smoking behavior patterns of their peers and parents. The smoking behavior patterns
influenced by peers and parents are most likely (1) the choice to smoke or abstain, and
(2) what brand is the peer approved brand to smoke.
Third, adolescents are known to engage in high-risk behavior patterns.
Adolescents love risk. They engage in unsafe premarital sex, drive fast, tend not to use
seat belts, experiment with drugs and alcohol, and do not use condoms; the list goes on.
No companies (that I know of) advertise to adolescents to motivate them to engage in
such risky behaviors, yet they engage in these behaviors nevertheless. Most likely these
behaviors are primarily manifestations of peer pressure and, normal rebellion.
FDA is proposing a simplistic solution to altering a highly complex pattern of
behavior. The naivete of the FDA's proposal to alter adolescent smoking patterns by
altering exposure to cigarette advertising and modifying cigarette health warnings is
apparent in the fact that smoking rates are declining most rapidly among inner city black
male teens and smoking is virtually non-existent among black female teens - a group i~
that, according to anti-smoking activists, has been unfairly targeted with advertising for 0
cigarettes. This is just one bit of anecdotal evidence that the determinates of smoking ~
behavior are far more complex than the simple view taken by FDA. o
cn
W
~
L'

s
For all of these reasons, in my opinion and based on my research, training and
experience the policy FDA has proposed can be predicted to be ineffective in reducing
underage smoking.
Submitted by,
Edward V. Morse, Ph.D.
Date
O
O
~
W
C32
_ ~
